$XRTX XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), Developing Orphan Drug Therapies To Slow Progressive Kidney Disease January, Investor Presentations https://www.xortx.com/investors/presentations